New drug trial aims to save lives from severe pneumonia
Disease control
Recruiting now
This study is testing if a drug called trimodulin, when added to standard hospital care, can help adults with severe pneumonia who are on a breathing machine. The main goal is to see if it lowers the risk of death within 28 days. About 590 participants will be randomly assigned t…
Phase: PHASE3 • Sponsor: Biotest • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC